Search Results
Apr 07, 2026, 00:02 ET Effat University Advances Digital Transformation with Ellucian Student and Finance Solutions
wife of late King Faisal, in 1999.Operating under the umbrella of King Faisal Foundation, Effat University offers rigorous bachelor, master and PhD programs that are nationally and internationally accredited within four colleges: Effat College of Humanities, Effat College of Engineering, Effat College
More news about: Ellucian
Apr 06, 2026, 12:32 ET PlateletDiagnostics Announces Novel Immune-Based Platelet Function Assay to Monitor Antiplatelet Therapy
an inexpensive, scalable way to monitor whether individual patients are adequately inhibited or resistant to therapy," said Robert Flaumenhaft, MD, PhD, Professor of Medicine and Chief of the Division of Hemostasis and Thrombosis at BIDMC, and co-founder of PlateletDiagnostics. "By bringing a platelet
More news about: PlateletDiagnostics, LLC
Apr 06, 2026, 11:00 ET DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
Session: Liquid Biopsies: Circulating Nucleic Acids 1Poster Section 44, Board 15 | Abstract #1134Presenter: Valsamo Anagnostou, MD, PhD, Johns Hopkins UniversityLung Cancer Subtyping Using Cell-Free DNA Fragmentomes and Protein BiomarkersSession:
More news about: DELFI Diagnostics
Apr 06, 2026, 10:00 ET NSC Study Highlights Benefits of Workplace Injury Prevention Technology
conversation about MSD prevention technology has centered on employers and developers – not the workers using these tools every day," said Paige DeBaylo, PhD, director of the MSD Solutions Lab at NSC. "Employers are looking for different ways to make their workers' jobs safer and less physically demanding.
More news about: National Safety Council
Apr 06, 2026, 08:04 ET SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
Sunita Misra, MD, PhD, Chief Medical Officer, SK Life Science, Inc. "The methodology behind the 'Hope, Hesitancy, and Hard Truths' survey provides important
More news about: SK Life Science, Inc.
Apr 06, 2026, 08:00 ET PinkDx Publishes Groundbreaking Evidence in Endometrial Cancer Detection Using a Simple Vaginal Swab
boards and is widely recognized for advancing patient-centered innovation in diagnostics.Giulia Kennedy, PhD — Co-Founder and Chief Scientific OfficerGiulia Kennedy, PhD, is co-founder and chief scientific officer of PinkDx. A molecular biologist and diagnostics innovator, she brings
More news about: PinkDx
Apr 02, 2026, 20:13 ET Your Body Thinks It's Protecting You. What If It's Wrong?
Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author Michael Norton, PhD, visionary violinist Vijay Gupta, chef and entrepreneur Ellen Bennett, artist Candy Chang, digital workplace expert and author Alexandra Samuel, PhD, grief experts
More news about: Unlikely Collaborators
Apr 02, 2026, 14:30 ET The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy
M. Eric Kohler, MD, PhD, an assistant professor of pediatrics in hematology, oncology, and bone marrow transplantation at
More news about: University of Colorado Anschutz
Apr 02, 2026, 11:30 ET Beckman Foundation Announces 2026 Arnold O. Beckman Postdoctoral Fellows
SciencesMegan Bentley, PhDUniversity of Colorado, BoulderEmily BoydMassachusetts Institute of TechnologyMentor: Dr. Yogesh Surendranath, 2x Previous AOB Postdoc MentorThomas Clarke, PhDNorthwestern UniversityMentor:
More news about: Arnold and Mabel Beckman Foundation
Apr 02, 2026, 10:16 ET Full Sail University to Open IBM Cyber Defense Range Powered by AWS and Cloud Range on Campus
carefully curated in collaboration with our partners at IBM to enhance the depth of knowledge our students acquire while at Full Sail," said Haifa Maamar, PhD., Executive Director of Emerging Technologies at Full Sail University. "The Full Sail University IBM Cyber Defense Range powered by AWS and Cloud Range strategically
More news about: Full Sail University
Apr 02, 2026, 09:42 ET The Lupus Research Alliance and Rheumatology Research Foundation Commit $1.9M to Empower Early-Career Scientists
varied clinical and research settings."Behind every discovery are dedicated investigators who need dependable support," said Teodora Staeva, PhD, Chief Scientific Officer of the Lupus Research Alliance. "This collaborative investment ensures early-career researchers can continue driving forward
More news about: Lupus Research Alliance
Apr 02, 2026, 09:07 ET Illumina Announces Changes to Board of Directors
2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced changes to its Board of Directors. Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, will retire from the Board in connection with the company's upcoming annual meeting of shareholders, and the Board has nominated
More news about: Illumina, Inc.
Apr 02, 2026, 09:07 ET NCCN Foundation Announces Annual Awards to Support Future Leaders for Cancer Innovation
Combined with Proton Craniospinal Irradiation for Patients with Melanoma and Leptomeningeal DiseaseYang Chen, PhD, The University of Texas MD Anderson Cancer Center Targeting Fibroinflammation to Prevent Resistance to KRAS Inhibition
More news about: National Comprehensive Cancer Network
Apr 02, 2026, 09:03 ET Landmark Study of 20,000 Users Provides Peer-Reviewed Proof: InsideTracker's AI Health Platform Linked to Significant, Sustained Health Biomarker Improvements
Renée Deehan, PhD, SVP of Science and AI at InsideTracker and one of the study's investigators. "This study is one piece of what we expect to be a much larger body of
More news about: InsideTracker
Apr 02, 2026, 09:00 ET Make Time Wellness Names Renowned Psychologist Nicole Beurkens, PhD as Scientific Advisor
Wellness, the rapidly growing women's brain health supplement line founded by Emma Heming Willis, today announced the appointment of Nicole Beurkens, PhD as its Scientific Advisor. A renowned holistic psychologist, Dr. Beurkens has spent 25 years developing research-based strategies that address the root
More news about: Make Time Wellness
Apr 02, 2026, 09:00 ET BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
decades building cancer programs at major academic medical centers and driving impressive clinical transformation at health systems," said Oguzhan Atay, PhD, co-founder and CEO of BillionToOne. "His deep expertise in cancer care, translational research, and clinical trial leadership is precisely what we need
More news about: BillionToOne
Apr 02, 2026, 08:30 ET Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
Matthew Oberley, MD, PhD, Senior Vice President, Chief Clinical Officer and Pathologist-in-Chief at Caris. "This launch reflects our commitment to delivering a single, integrated
More news about: Caris Life Sciences
Apr 02, 2026, 08:15 ET CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials
LinkedIn.Media ContactsCellCarta:Stéphanie Bussières-Marmen, PhDDirector, Global [email protected] Biosciences:Brian
More news about: CellCarta
Apr 02, 2026, 08:07 ET New Research: As America approaches its 250th anniversary, a powerful "Unity Mandate" is emerging for brands to bridge divides
to manufacture that sentiment or take a risk to embrace it. They simply have to show up and reflect it authentically," said Tricia Richards-Service, PhD, Adjunct Professor of Practice, Public Relations at Wake Forest University.
More news about: M Booth & Associates, Inc.
Apr 02, 2026, 07:47 ET Zeto Announces FDA 510(k) Clearance of Zeto New Wave™, Advancing Efficiency in Outpatient EEG
patients."New Wave™ is our newest outpatient EEG system, built on lessons learned from our first-generation device, the Zeto WR19," said Florian Strelzyk, PhD, CEO of Zeto. "We listened to neurologists' needs and designed a system that helps clinics expand access to EEG, address staffing challenges, and improve
More news about: Zeto, Inc.
Apr 02, 2026, 07:30 ET PanGIA Biotech Announces Peer-Reviewed Study in Diagnostics Showing 97.8% Sensitivity in Detecting Prostate Cancer Using a Urine-Based Liquid Biopsy with Machine Learning
approach to early cancer detection and monitoring."This study reflects a different way of approaching cancer detection," said Obdulio Piloto, PhD, Chief Scientific Officer and Co-Founder of PanGIA Biotech. "Rather than targeting a single biomarker, this urine-based liquid biopsy uses machine learning
More news about: PanGIA Biotech
Apr 02, 2026, 07:30 ET Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
publication in Oncology and Therapy is a privilege and highlights the clinical significance of our work with HyBryte™," stated Brian Poligone, MD, PhD, Director of the Rochester Skin Lymphoma Medical Group, Fairport, NY, and Principal Investigator for the comparability study. "Despite the small study
More news about: SOLIGENIX, INC.
Apr 02, 2026, 07:00 ET Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
antibody response." Zhenping Zhu, MD, PhD, President & Co-CEO of Earendil Labs, commented, "We are working diligently to advance HXN-1001 clinical programs in a hope to bring a new and efficacious therapeutic option for IBD patients expeditiously."Jian Peng, PhD, CEO of Earendil Labs, stated, "The
More news about: Earendil Labs
Apr 02, 2026, 07:00 ET WindRose Health Investors Launches WindRose Gradient, a Dedicated Technology Services Team to Support Portfolio Company AI Capabilities
work by the Special Interest Group on Information Retrieval (SIGIR) and the Association of Computational Linguistics (ACL). Mr. Berger received his PhD in computer science from Carnegie Mellon University."Companies that are first to incorporate AI across their organizations will realize significant
More news about: WindRose Health Investors
Apr 02, 2026, 05:55 ET New Paper in Translational Insights Presents a Unifying Theory for How the Immune System Recognizes Cancer
characterization, and validated clinical outcomes. With research operations in Boston, Nashville and Tijuana, TAM Global is a multidisciplinary team of 16 PhD scientists and 42 Medical doctors with a decade-long commitment to advancing regenerative medicine and cancer therapeutics. TAM Global is setting new
More news about: The TAM Center